XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Paid in Capital
Statutory Reserves
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 7,963 $ 164,870,025 $ 15,191,645 $ (10,326,595) $ (60,497,371) $ 109,245,667
Balance (in Shares) at Dec. 31, 2023 7,963,444          
Net loss for the period (279,797) (279,797)
Conversion of long-term notes into common shares $ 165 321,078 321,243
Conversion of long-term notes into common shares (in Shares) 165,081          
Transfer to statutory reserves 31 (31)
Foreign currency translation gain (loss) (118,621) (118,621)
Balance at Mar. 31, 2024 $ 8,128 165,191,103 15,191,676 (10,445,216) (60,777,199) 109,168,492
Balance (in Shares) at Mar. 31, 2024 8,128,525          
Balance at Dec. 31, 2023 $ 7,963 164,870,025 15,191,645 (10,326,595) (60,497,371) 109,245,667
Balance (in Shares) at Dec. 31, 2023 7,963,444          
Net loss for the period           (689,554)
Foreign currency translation gain (loss)           (767,810)
Balance at Jun. 30, 2024 $ 8,516 165,329,781 15,191,645 (11,094,405) (61,186,925) 108,248,612
Balance (in Shares) at Jun. 30, 2024 8,516,357          
Balance at Mar. 31, 2024 $ 8,128 165,191,103 15,191,676 (10,445,216) (60,777,199) 109,168,492
Balance (in Shares) at Mar. 31, 2024 8,128,525          
Net loss for the period (409,757) (409,757)
Conversion of long-term notes into common shares $ 259 (259)
Conversion of long-term notes into common shares (in Shares) 259,067          
Transfer to statutory reserves (31) 31
Stock compensation expense $ 129 138,937 139,066
Stock compensation expense (in Shares) 128,765          
Foreign currency translation gain (loss) (649,189) (649,189)
Balance at Jun. 30, 2024 $ 8,516 165,329,781 15,191,645 (11,094,405) (61,186,925) 108,248,612
Balance (in Shares) at Jun. 30, 2024 8,516,357          
Balance at Dec. 31, 2024 $ 9,161 165,959,857 15,191,645 (14,373,199) (62,056,383) $ 104,731,081
Balance (in Shares) at Dec. 31, 2024 9,161,218         7,391,996
Net loss for the period (884,460) $ (884,460)
Foreign currency translation gain (loss) 584,206 584,206
offering of the common stock $ 15,330 9,850,070 9,865,400
offering of the common stock (in Shares) 15,329,851          
Balance at Mar. 31, 2025 $ 24,491 175,809,927 15,191,645 (13,788,993) (62,940,843) 114,296,227
Balance (in Shares) at Mar. 31, 2025 24,491,069          
Balance at Dec. 31, 2024 $ 9,161 165,959,857 15,191,645 (14,373,199) (62,056,383) $ 104,731,081
Balance (in Shares) at Dec. 31, 2024 9,161,218         7,391,996
Net loss for the period           $ (2,129,276)
Foreign currency translation gain (loss)           2,220,380
Balance at Jun. 30, 2025 $ 25,305 177,209,736 15,191,645 (12,152,819) (64,185,659) $ 116,088,208
Balance (in Shares) at Jun. 30, 2025 25,305,012         24,491,069
Balance at Mar. 31, 2025 $ 24,491 175,809,927 15,191,645 (13,788,993) (62,940,843) $ 114,296,227
Balance (in Shares) at Mar. 31, 2025 24,491,069          
Net loss for the period (1,244,816) (1,244,816)
Conversion of long-term notes into common shares $ 690 568,413 569,103
Conversion of long-term notes into common shares (in Shares) 689,817          
Stock compensation expense $ 124 831,396 831,520
Stock compensation expense (in Shares) 124,126          
Foreign currency translation gain (loss) 1,636,174 1,636,174
Balance at Jun. 30, 2025 $ 25,305 $ 177,209,736 $ 15,191,645 $ (12,152,819) $ (64,185,659) $ 116,088,208
Balance (in Shares) at Jun. 30, 2025 25,305,012         24,491,069